The range of modalities available for wound management
is extensive and can be categorized into four main groups:
- Conventional therapies
include traditional dressings, with or without topical antimicrobial agents or
growth factors, and biological dressings such as silver or alginate. Other
approaches, like hyperbaric oxygen therapy, are also used [3].
- Novel therapies utilize
advancements like platelet-rich plasma, negative pressure wound therapy (NPWT),
and skin substitutes, which are minimally invasive and show improved healing
efficacy compared to conventional methods [4].
- Reconstructive therapies,
such as skin and flap grafting, are invasive procedures that may also damage
surrounding healthy tissue.
- Cell-based therapy is a
rapidly growing field in wound management, often used in combination with other
modalities. Stem cells for these therapies can be sourced from bone marrow or
adipose tissue [5].
The clinical application of autologous adipose-derived
stem cells (ASCs) is expanding across diverse areas, including wound healing
and regenerative medicine. ASCs exhibit pluripotency, survive transplantation
while demonstrating anti-apoptotic, anti-inflammatory, and angiogenic effects.
Stromal vascular fraction (SVF) is a heterogeneous mix
of cells derived from enzymatic or mechanical processing of adipose tissue. It
has shown promising regenerative, immunomodulatory, and anti-inflammatory
properties. SVF plays a role in all three phases of wound healing:
- Inflammatory phase: SVF
reduces active scar formation by decreasing mast cells and myofibroblasts
through its immunosuppressive and anti-inflammatory effects.
- Proliferative phase:
Adipose-derived stem cells and growth factors in SVF promote tissue
regeneration and healing.
- Maturation phase: SVF
suppresses excessive collagen synthesis and remodels collagen via chemokines
like TGF-beta3 and matrix metalloproteinases, enhancing scar pliability and
quality.
SVF also contains growth factors such as
Platelet-Derived Growth Factor (PDGF), Insulin-Like Growth Factor (IGF),
Keratinocyte Growth Factor (KGF), Basic Fibroblast Growth Factor (bFGF), and
Vascular Endothelial Growth Factor (VEGF), which accelerate healing and
contribute to improved scar outcomes. The modulation of collagen synthesis and
fibroblast migration further enhances scar pliability [6]. Purification of SVF
is crucial for therapeutic use to remove non-functional or harmful components
and enrich the cell population for safer and more effective application. SVF
preparation can be performed using enzymatic (Figure 9) or mechanical methods.
Enzymatic digestion, while efficient, may lead to higher CD45 contamination
compared to mechanical methods, which provide cleaner but lower yields and
require longer culture times [7]. In our study, we employed readily available
materials to prepare SVF mechanically and used it for scar management. The
resulting scar showed improved quality, with the patient expressing
satisfaction with the outcome.